nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazoline—Phentermine—SLC6A4—chronic obstructive pulmonary disease	0.0126	0.193	CrCbGaD
Tolazoline—Phentermine—CYP1A2—chronic obstructive pulmonary disease	0.0115	0.176	CrCbGaD
Tolazoline—Benzyl alcohol—CYP1A1—chronic obstructive pulmonary disease	0.0115	0.176	CrCbGaD
Tolazoline—Benzyl alcohol—CYP1A2—chronic obstructive pulmonary disease	0.011	0.169	CrCbGaD
Tolazoline—Amphetamine—SLC6A4—chronic obstructive pulmonary disease	0.00967	0.148	CrCbGaD
Tolazoline—Methamphetamine—SLC6A4—chronic obstructive pulmonary disease	0.00897	0.138	CrCbGaD
Tolazoline—ADRA2C—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.00109	0.00117	CbGpPWpGaD
Tolazoline—HRH1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.00109	0.00116	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.00108	0.00116	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.00108	0.00115	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.00107	0.00114	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.00107	0.00114	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00105	0.00112	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.00104	0.00112	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—GC—chronic obstructive pulmonary disease	0.00102	0.00109	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.001	0.00107	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000998	0.00107	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000996	0.00106	CbGpPWpGaD
Tolazoline—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.000995	0.00106	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000992	0.00106	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000982	0.00105	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000977	0.00105	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000964	0.00103	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000963	0.00103	CbGpPWpGaD
Tolazoline—HRH1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000951	0.00102	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000949	0.00102	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000945	0.00101	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000934	0.000999	CbGpPWpGaD
Tolazoline—ADRA2C—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.00093	0.000994	CbGpPWpGaD
Tolazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000927	0.000992	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000917	0.000981	CbGpPWpGaD
Tolazoline—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	0.000913	0.000977	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000908	0.000971	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000901	0.000963	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000886	0.000947	CbGpPWpGaD
Tolazoline—ADRA2A—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000885	0.000947	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000879	0.00094	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000878	0.000939	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000877	0.000938	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000867	0.000928	CbGpPWpGaD
Tolazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000866	0.000927	CbGpPWpGaD
Tolazoline—ADRA2C—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	0.000853	0.000913	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000827	0.000885	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000826	0.000884	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000819	0.000876	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000817	0.000874	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000772	0.000826	CbGpPWpGaD
Tolazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000772	0.000826	CbGpPWpGaD
Tolazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.000762	0.000815	CbGpPWpGaD
Tolazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000757	0.00081	CbGpPWpGaD
Tolazoline—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.000755	0.000808	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000754	0.000806	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.00075	0.000803	CbGpPWpGaD
Tolazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.000748	0.0008	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000746	0.000798	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000745	0.000797	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000744	0.000796	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000739	0.00079	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000731	0.000782	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.00073	0.00078	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000716	0.000766	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000712	0.000762	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000707	0.000756	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000706	0.000756	CbGpPWpGaD
Tolazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000704	0.000753	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000701	0.00075	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000697	0.000745	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000695	0.000744	CbGpPWpGaD
Tolazoline—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	0.000693	0.000741	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.00069	0.000738	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000688	0.000736	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000687	0.000735	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000679	0.000726	CbGpPWpGaD
Tolazoline—HRH2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000679	0.000726	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000675	0.000722	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000674	0.000721	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000672	0.000719	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000671	0.000717	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000665	0.000712	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000665	0.000711	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.00066	0.000706	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.00066	0.000706	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000646	0.000691	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000627	0.000671	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000626	0.00067	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000625	0.000668	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000619	0.000663	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000616	0.000659	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000615	0.000657	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000613	0.000656	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000612	0.000655	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000603	0.000646	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000603	0.000645	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000589	0.00063	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000588	0.000629	CbGpPWpGaD
Tolazoline—HRH1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000588	0.000629	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000587	0.000628	CbGpPWpGaD
Tolazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	0.000585	0.000626	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000577	0.000617	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000577	0.000617	CbGpPWpGaD
Tolazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	0.000575	0.000615	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000571	0.000611	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000569	0.000609	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000566	0.000605	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000565	0.000604	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.00056	0.000599	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000558	0.000597	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000558	0.000597	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000551	0.00059	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000548	0.000586	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000548	0.000586	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000548	0.000586	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.00054	0.000578	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000538	0.000575	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000536	0.000574	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000536	0.000573	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000528	0.000564	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000517	0.000553	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.000513	0.000549	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000509	0.000544	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000503	0.000538	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.00049	0.000524	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000488	0.000522	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000483	0.000516	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.00048	0.000514	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.000479	0.000513	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000479	0.000512	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000476	0.000509	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.000471	0.000504	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000469	0.000502	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000464	0.000496	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.00045	0.000482	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000449	0.00048	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000445	0.000476	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000443	0.000474	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.00044	0.00047	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000437	0.000468	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.00043	0.00046	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.00043	0.00046	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000422	0.000451	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000415	0.000444	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000414	0.000443	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.00041	0.000439	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.0004	0.000428	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000399	0.000427	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000396	0.000424	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000392	0.00042	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000392	0.000419	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.000389	0.000416	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—TP53—chronic obstructive pulmonary disease	0.000388	0.000415	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000387	0.000414	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000381	0.000408	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000373	0.000399	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.00037	0.000396	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000369	0.000395	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000364	0.00039	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000364	0.000389	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000362	0.000388	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—TP53—chronic obstructive pulmonary disease	0.000362	0.000387	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000362	0.000387	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.00036	0.000385	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.000357	0.000382	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000355	0.00038	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000347	0.000371	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	0.000346	0.00037	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000339	0.000362	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000337	0.00036	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000336	0.00036	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000336	0.00036	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000332	0.000355	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.00033	0.000353	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.000329	0.000352	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000326	0.000349	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000324	0.000346	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000324	0.000346	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000322	0.000345	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000303	0.000324	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000302	0.000323	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000301	0.000322	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000301	0.000322	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.0003	0.000321	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000296	0.000317	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	0.000296	0.000316	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—TP53—chronic obstructive pulmonary disease	0.000294	0.000315	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000294	0.000315	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000288	0.000309	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000283	0.000303	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—ALB—chronic obstructive pulmonary disease	0.000282	0.000302	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000275	0.000294	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000273	0.000292	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	0.000271	0.00029	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—NOS3—chronic obstructive pulmonary disease	0.00027	0.000288	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000268	0.000287	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	0.000266	0.000285	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000265	0.000283	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000263	0.000281	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000263	0.000281	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000253	0.00027	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000247	0.000265	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000244	0.000262	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000241	0.000258	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000236	0.000253	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	0.000229	0.000245	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000225	0.000241	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	0.000223	0.000239	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.00022	0.000236	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000219	0.000234	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000216	0.000231	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000214	0.000229	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.00021	0.000225	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000206	0.000221	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	0.000205	0.000219	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	0.000204	0.000218	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000201	0.000215	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000201	0.000215	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.0002	0.000214	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000197	0.000211	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.000194	0.000207	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000192	0.000205	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	0.00019	0.000203	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000183	0.000196	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.000181	0.000194	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000178	0.000191	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000175	0.000187	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	0.000174	0.000186	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	0.000169	0.000181	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	0.000166	0.000178	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000162	0.000174	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	0.000162	0.000174	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.000161	0.000172	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	0.00016	0.000171	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.000158	0.000169	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	0.000156	0.000167	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	0.000154	0.000165	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	0.000149	0.000159	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.000147	0.000157	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	0.000146	0.000156	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	0.000145	0.000155	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	0.000142	0.000152	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	0.000133	0.000142	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	0.000132	0.000141	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	0.000131	0.000141	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	0.00013	0.000139	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	0.00013	0.000139	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	0.000128	0.000137	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	0.000123	0.000131	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	0.000121	0.00013	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	0.00012	0.000129	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	0.000119	0.000127	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	0.000112	0.00012	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	0.000109	0.000117	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	0.000107	0.000115	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	0.0001	0.000107	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	9.97e-05	0.000107	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.82e-05	0.000105	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.13e-05	9.76e-05	CbGpPWpGaD
